OHV: Focused Ultrasound For Tissue Heat Or Mechanical Cellular Disruption
What it covers
A device using focused ultrasound to produce localized, mechanical motion within tissues and cells for the purpose of producing either localized heating for tissue coagulation or for mechanical cellular membrane disruption intended for non-invasive aesthetic use.
FDA’s definition of product code OHV, from the Product Classification database.
Recent clearances
| 510(k) | Device | Applicant | Decision | Type |
|---|---|---|---|---|
| K260618 | Ulthera® System | Ulthera, Inc. | May 21, 2026 | Traditional |
| K250418 | Ulthera System (UC-1 Control Unit PRIME Model 2.1) | Ulthera, Inc. | May 13, 2025 | Traditional |
| K243035 | Ulthera® System | Ulthera, Inc. | Feb 24, 2025 | Traditional |
| K240687 | SofWave System | Sofwave Medical, Ltd. | May 30, 2024 | Traditional |
| K233996 | Ulthera System (UC-1 Control Unit PRIME) | Ulthera, Inc. | Feb 22, 2024 | Special |
| K233104 | SofWave System | Sofwave Medical, Ltd. | Dec 22, 2023 | Traditional |
| K232455 | SofWave System | Sofwave Medical, Ltd. | Dec 14, 2023 | Traditional |
| K230100 | SCIZER (SC1-M410) | Classys, Inc. | Nov 3, 2023 | Traditional |
| K231628 | BeShape One Device | Beshape Technologies , Ltd. | Sep 29, 2023 | Traditional |
| K231537 | SofWave System | Sofwave Medical, Ltd. | Aug 28, 2023 | Traditional |
Clearances by year
29 OHV 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.
| Year | Clearances | Median days to decision |
|---|---|---|
| 2026 (so far) | 1 | 85 |
| 2025 | 2 | 120 |
| 2024 | 2 | 73 |
| 2023 | 7 | 90 |
| 2022 | 1 | 58 |
| 2021 | 1 | 187 |
| 2019 | 2 | 282 |
| 2018 | 1 | 56 |
| 2017 | 1 | 98 |
| 2016 | 3 | 107 |
| 2014 | 3 | 171 |
| 2013 | 1 | 163 |
| 2012 | 2 | 63 |
| 2011 | 2 | 274 |
Who submits
7 applicants cleared a OHV device since 2011. 48% of the clearances went to applicants in Israel, then United States (45%) and South Korea (7%). By type: Traditional 90% and Special 10%.
| Applicant | Clearances since 2011 |
|---|---|
| Sofwave Medical, Ltd. | 9 |
| Ulthera, Inc. | 9 |
| Syneron Medical, Ltd. | 6 |
| Medicis Technologies Corporation | 2 |
| Beshape Technologies , Ltd. | 1 |
| Classys, Inc. | 1 |
| Jeisys Medical, Inc. | 1 |
How FDA classifies it
Class II (special controls). The special control for this device is FDA's “Class II Special Controls Guidance Document: Focused Ultrasound Stimulator System for Aesthetic Use.” See § 878.1(e) for the availability of this guidance document.
From 21 CFR 878.4590. Special controls are the requirements a 510(k) must show it meets.
Standards
21 CFR 878.4590 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent OHV clearances declared.
Ask about OHV
Questions about OHV
What is FDA product code OHV?
Product code OHV, “Focused Ultrasound For Tissue Heat Or Mechanical Cellular Disruption” in FDA's classification database, is a Class II device type under 21 CFR 878.4590 (focused ultrasound stimulator system for aesthetic use), reviewed by FDA's General, Plastic Surgery panel. FDA's 510(k) database lists 30 clearances under OHV, 29 of them since 2011.
How many 510(k) clearances are there under OHV?
FDA’s 510(k) database listed 30 clearances under OHV as of Oct 29, 2026, 29 of them decided since 2011; the most recent decision was May 21, 2026. The Predicate Finder searches the live database.
How long does FDA take to clear a OHV 510(k)?
For the 3 OHV clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 89 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.
Which companies have the most OHV clearances?
Since 2011: Sofwave Medical, Ltd. (9), Ulthera, Inc. (9), Syneron Medical, Ltd. (6), Medicis Technologies Corporation (2) and Beshape Technologies , Ltd. (1). 7 applicants have cleared a OHV device in that time.